NASDAQ · Medical - Distribution

GEG (GEG) Stock

$2.18 -0.46% NASDAQ: GEG Healthcare

Valuation

MetricValue
Price$2.18
Market Cap$68.36M
P/E Ratio6.61
P/B Ratio0.98
P/S Ratio2.99
EPS (TTM)$0.33
52-Week High$3.51
52-Week Low$1.80
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE18.57%
ROA8.44%
ROCE-9.88%
Gross Margin-50.00%
Operating Margin-50.00%
Net Margin-1.00%
Debt/Equity1.59
Current Ratio13.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$61.0M$5.0M$9.0M$18.0M$16.0M
Operating Profit$-4.0M$-9.0M$-11.0M$-8.0M$-8.0M
Net Profit$-7.0M$-15.0M$28.0M$-1.0M$13.0M
EPS$-0.29$-0.56$0.40$-0.05$0.33
Op Margin-6.1%-193.6%-129.4%-44.0%-49.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$162.0M$168.0M$136.0M$140.0M$154.0M
Total Liabilities$106.0M$126.0M$72.0M$70.0M$73.0M
Cash$24.0M$22.0M$60.0M$51.0M$35.0M
Borrowings$41.0M$71.0M$63.0M$61.0M$63.0M

Latest News

Great Elm Group Q3 Earnings Call Highlights MarketBeat · May 7, 2026 Great Elm Group, Inc. Q3 2026 Earnings Call Summary Moby · May 7, 2026 Great Elm Group Reports Fiscal 2026 Third Quarter Financial Results GlobeNewswire · May 6, 2026 Great Elm Group, Inc. Schedules Fiscal 2026 Third Quarter Conference Call and Webcast GlobeNewswire · May 5, 2026 Great Elm Capital Corp. Announces First Quarter 2026 Financial Results GlobeNewswire · May 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$29.0M$-2.0M$-16.0M$-9.0M
Investing Cash Flow$-22.0M$-41.0M$84.0M$2.0M$-1.0M
Financing Cash Flow$10.0M$-16.0M$-6.0M$5.0M$-7.0M
Net Cash Flow$-16.0M$-2.0M$38.0M$-10.0M$-19.0M
Free Cash Flow$-26.0M$28.0M$-2.0M$-16.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield16.76%
Quick Ratio12.21
Interest Coverage-2.00
Return 1Y5.88%
Return 3Y8.00%
Return 5Y-5.26%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACET $8.30 +1.22% -0.46 $77.59M 0.00%
ASRT $23.44 +0.30% -4.95 $151.47M 0.00%
EDAPEdap Tms S.a. $4.76 -0.52% -6.63 $178.23M 0.00%
FORA $2.17 +0.00% -24.11 $67.79M 0.00%
IMUXImmunic, Inc. $13.81 +3.14% -2.24 $188.11M 0.00%

About GEG

GEG is led by CEO Jason W. Reese, employs 31 people, headquartered in US, publicly traded since 1999.

GEG stock trades at $2.18 with a market capitalization of $68.36M. The stock is valued at a price-to-earnings (P/E) ratio of 6.61, price-to-book of 0.98, price-to-sales of 2.99. Over the past 52 weeks the stock has ranged between $1.80 and $3.51, and currently trades 37.9% below its 52-week high.

On profitability, GEG generates a return on equity (ROE) of 18.57%, above the typical market average, return on capital employed of -9.88%, an operating margin of -50.00%, a net profit margin of -1.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides